Source: NSE
What would have to hold for each case — not a price target or a projected figure. CapitSignal does not forecast where this stock trades.
The company successfully expands its product portfolio to include high-demand items like Maltodextrin powder and Liquid glucose.
The filing indicates that Regaal is diversifying its product offerings to capture more market share.
Maize production in India continues to grow at a CAGR of 7.3% as projected.
The industry overview highlights that maize production is expected to increase, supporting supply for Regaal's operations.
Revenue growth follows the historical trend of 25.68% CAGR from FY22 to FY24.
The filing shows that Regaal has achieved significant revenue growth in recent fiscal years.
The company maintains its current customer base without significant losses.
The prospectus notes that the loss of major customers could materially impact the business.
Top customers reduce their purchases significantly.
The filing states that the loss of key customers would have a material adverse impact on the business.
Supply chain disruptions occur, affecting maize procurement.
The prospectus mentions that delays or interruptions in raw material supply could adversely affect production.